Skip to main content
. 2020 Jan 24;2020:6585264. doi: 10.1155/2020/6585264

Table 1.

Patient characteristics.

Patients Age (years) Sex PD duration (years) MDS-UPDRS Total (ON) MDS-UPDRS Part II-1 (speech) MDS-UPDRS Part III-1 (speech) HY Raven CPM
1 52 F 4 32 1 1 3 34
2 71 M 25 43 2 2 3 30
3 77 M 2 23 1 2 3 32
5 68 M 9 44 1 1 2 32
6 65 F 5 40 2 2 3 34
7 66 M 9 37 1 2 3 34
8 68 M 5 40 2 2 2 30
9 70 M 19 74 1 1 3 34
10 69 M 13 78 4 4 3 20
11 51 F 3 33 3 1 2 35
12 60 F 3 30 2 2 3 28
13 63 M 8 26 0 0 2 36
14 74 F 13 18 0 0 2 30
15 73 F 3 18 1 1 1 35
16 67 F 10 15 1 1 1 29
17 68 M 12 57 3 3 3 27
18 55 M 5 18 1 2 3 29
19 66 M 9 47 0 2 3 32
20 85 F 10 57 1 1 4 32
21 65 M 15 62 2 1 2 30
22 68 M 4 26 3 1 2 30

The patients are listed in order of participation in the study. M: male; F: female; PD: Parkinson's disease; MDS-UPDRS: Modified Unified Parkinson's Disease Rating Scale; HY: Hoehn & Yahr Scale stage; CPM: Colored Progressive Matrices.